AFP and hepatocellular carcinoma: However, patient and graft survival was inferior in DCD donors compared to DBD donors when analyzing the high-risk HCC recurrence population (AFP at LT > 100 ng/mL, progressive disease after LRT, or a RETREAT score > 4) [62].